Invex Therapeutics Ltd. (AU:IXC) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Invex Therapeutics Ltd. has announced the cessation of 50,000 options due to the lapse of conditions that were not or could not be satisfied, effective June 28, 2024. The options, identified by the ASX security code IXCAI and expiring on December 1, 2026, were worth $0.68 each.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.